Allison Eddy

Q: What Schools Are Affiliated With Allison Eddy

Allison Eddy is affiliated with the following schools: Ohio State University, University of Minnesota, University of British Columbia, McMaster University, University of Toronto, University of Washington

Allison Eddy's AcademicInfluence.com Rankings

Allison Eddy

Philosophy

#10120

World Rank

#13841

Historical Rank

Logic

#7051

World Rank

#8671

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Allison Eddy Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Allison Audrey Eddy is a Canadian nephrologist. She was the inaugural Hudson Family Hospital Chair in Pediatric Medicine at British Columbia Children's Hospital and a clinician-scientist at the British Columbia Children's Hospital.

(See a Problem?)

Allison Eddy's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Nephrotic syndrome in childhood (2003) (774)
Macrophage diversity in renal injury and repair. (2008) (686)
Molecular basis of renal fibrosis (2000) (628)
Molecular insights into renal interstitial fibrosis. (1996) (619)
Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. (1995) (380)
Progression in chronic kidney disease. (2005) (325)
Interstitial nephritis induced by protein-overload proteinuria. (1989) (306)
PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. (2001) (263)
Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. (1994) (251)
The NPHP1 gene deletion associated with juvenile nephronophthisis is present in a subset of individuals with Joubert syndrome. (2004) (247)
Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action. (2006) (221)
Overview of the cellular and molecular basis of kidney fibrosis (2014) (199)
Plasminogen activator inhibitor-1 and the kidney. (2002) (191)
Chronic kidney disease progression. (2006) (186)
Why is proteinuria an ominous biomarker of progressive kidney disease? (2004) (180)
Proteinuria and interstitial injury. (2004) (167)
Immune cell populations in cutaneous delayed-type hypersensitivity (1983) (165)
Critical and honest conversations: the evidence behind the "Choosing Wisely" campaign recommendations by the American Society of Nephrology. (2012) (160)
Longterm followup of childhood lupus nephritis. (2002) (153)
Neurologic manifestations of pediatric systemic lupus erythematosus. (1995) (146)
Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis. (1991) (142)
A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome. (1991) (138)
Multifunctionality of PAI-1 in fibrogenesis: evidence from obstructive nephropathy in PAI-1-overexpressing mice. (2005) (132)
Investigating mechanisms of chronic kidney disease in mouse models (2012) (129)
Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats. (1992) (127)
CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD. (2009) (127)
Acute tubulointerstitial nephritis associated with aminonucleoside nephrosis. (1988) (126)
TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy. (2001) (122)
Interstitial inflammation and fibrosis in rats with diet-induced hypercholesterolemia. (1996) (113)
Interstitial fibrosis in mice with overload proteinuria: deficiency of TIMP-1 is not protective. (2000) (112)
Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy. (2003) (104)
Plasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: role of plasmin-activated signals. (2007) (100)
Protein restriction reduces transforming growth factor-beta and interstitial fibrosis in nephrotic syndrome. (1994) (88)
A Novel Signaling Pathway (2009) (88)
Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis. (2011) (84)
Role of cellular infiltrates in response to proteinuria. (2001) (83)
Antiribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis. (1996) (83)
Serine proteases, inhibitors and receptors in renal fibrosis (2009) (72)
Pseudohermaphroditism, glomerulopathy, and Wilms tumor (Drash syndrome): frequency in end-stage renal failure. (1985) (71)
Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group. (2010) (71)
Atherogenic scavenger receptor modulation in the tubulointerstitium in response to chronic renal injury. (2007) (70)
Interstitial fibrosis in hypercholesterolemic rats: role of oxidation, matrix synthesis, and proteolytic cascades. (1998) (69)
Urokinase receptor modulates cellular and angiogenic responses in obstructive nephropathy. (2003) (68)
Expression of genes that promote renal interstitial fibrosis in rats with proteinuria. (1996) (63)
Mannose receptor 2 attenuates renal fibrosis. (2012) (60)
Interstitial macrophages as mediators of renal fibrosis. (1995) (59)
Tubulointerstitial nephritis and uveitis in children and adolescents (1999) (57)
Tubulointerstitial nephritis (2004) (56)
The distribution of the CR3 receptor on human cells and tissue as revealed by a monoclonal antibody. (1984) (51)
Cysteamine modulates oxidative stress and blocks myofibroblast activity in CKD. (2014) (51)
Can renal fibrosis be reversed? (2005) (49)
Single photon emission computed tomography scanning in childhood systemic lupus erythematosus. (1998) (42)
Establishing core outcome domains in pediatric kidney disease: report of the Standardized Outcomes in Nephrology - Children and Adolescents (SONG-KIDS) consensus workshops. (2020) (41)
Presence of thyroid abnormalities in children with systemic lupus erythematosus. (1991) (41)
Intrarenal distribution of clusterin following reduction of renal mass. (1992) (41)
Standardised Outcomes in Nephrology—Children and Adolescents (SONG-Kids): a protocol for establishing a core outcome set for children with chronic kidney disease (2016) (39)
Plasminogen Activator Inhibitor-1 Deficiency Has Renal Benefits but Some Adverse Systemic Consequences in Diabetic Mice (2006) (38)
Endogenous urokinase lacks antifibrotic activity during progressive renal injury. (2007) (38)
Renal allograft failure due to recurrent dense intramembranous deposit disease. (1984) (37)
Child and Parental Perspectives on Communication and Decision Making in Pediatric CKD: A Focus Group Study. (2018) (37)
Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study Group. (2009) (37)
The origin of scar-forming kidney myofibroblasts (2013) (36)
Urokinase and its receptors in chronic kidney disease. (2008) (35)
Albumin-induced apoptosis of glomerular parietal epithelial cells is modulated by extracellular signal-regulated kinase 1/2. (2012) (34)
Range and Heterogeneity of Outcomes in Randomized Trials of Pediatric Chronic Kidney Disease (2017) (33)
Chapter 21 – SYSTEMIC LUPUS ERYTHEMATOSUS (2011) (33)
Acute kidney injury and its association with in-hospital mortality among children with acute infections (2013) (33)
Expression of nephrin in acquired forms of nephrotic syndrome in childhood (2004) (31)
Mast cells find their way to the kidney. (2001) (31)
Identification of lymphohemopoietic cells in the kidneys of normal rats. (1986) (27)
The nephrotic syndrome: from the simple to the complex. (1998) (27)
Localization of clusterin in the epimembranous deposits of passive Heymann nephritis. (1991) (27)
Xanthogranulomatous Pyelonephritis in Children (1994) (26)
Expression and function of monocyte chemoattractant protein-1 in experimental nephrotic syndrome. (1996) (26)
Identifying Important Outcomes for Young People With CKD and Their Caregivers: A Nominal Group Technique Study. (2019) (25)
Subtotal nephrectomy in the rabbit: a model of chronic hypercalcemia, nephrolithiasis, and obstructive nephropathy. (1986) (24)
Exogenous Bone Morphogenetic Protein-7 Fails to Attenuate Renal Fibrosis in Rats with Overload Proteinuria (2004) (24)
Vascular Endothelial Cadherin Modulates Renal Interstitial Fibrosis (2011) (24)
Demonstration by light microscopy of cytomegalovirus on a renal biopsy of a renal allograft recipient: confirmation by immunohistochemistry and in situ hybridization. (1987) (23)
The Canadian Childhood Nephrotic Syndrome (CHILDNEPH) Project: overview of design and methods (2014) (20)
Scraping fibrosis: UMODulating renal fibrosis (2011) (20)
Vitronectin accumulates in the interstitium but minimally impacts fibrogenesis in experimental chronic kidney disease. (2011) (17)
Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein. (2004) (17)
Coagulation abnormalities in chronic peritoneal dialysis (1990) (16)
Drug-induced tubulointerstitial nephritis: hypersensitivity and necroinflammatory pathways (2019) (16)
Pathophysiology of Progressive Renal Disease (2009) (16)
Intraglomerular leukocyte recruitment during nephrotoxic serum nephritis in rats. (1990) (15)
Nicotinic acetylcholine receptor α1 promotes calpain-1 activation and macrophage inflammation in hypercholesterolemic nephropathy (2011) (15)
The contribution of antibody-mediated cytotoxicity and immune-complex formation to tubulointerstitial disease in passive Heymann nephritis. (1992) (14)
Prolongation of acute renal failure in two patients with hemolytic-uremic syndrome due to excessive plasma infusion therapy (1989) (13)
The impact of small kidneys (2015) (13)
Pseudohermaphroditism, Glomerulopathy, and Wilms’ Tumor (Drash Syndrome): Frequency in End-Stage Renal Failure (1985) (12)
Renal remodelling in dietary protein modified rat polycystic kidney disease (1999) (10)
Developing Consensus-Based Outcome Domains for Trials in Children and Adolescents With CKD: An International Delphi Survey. (2020) (9)
Uromodulin deficiency alters tubular injury and interstitial inflammation but not fibrosis in experimental obstructive nephropathy (2018) (9)
Ramping up endogenous defences against chronic kidney disease. (2006) (8)
Failure of antioxidant therapy to attenuate interstitial disease in rats with reversible nephrotic syndrome. (1998) (8)
Tubulointerstitial nephritis during the heterologous phase of nephrotoxic serum nephritis. (1991) (8)
Decreased plasma fibronectin levels in children with hemolytic-uremic syndrome. (1985) (7)
The TGF-β route to renal fibrosis is not linear: the miR-21 viaduct. (2011) (5)
Pulmonary hemorrhage and necrotizing glomerulonephritis without glomerular immune deposits: report of two cases. (1991) (5)
Characterization of the NC1 domain of collagen type IV in glomerular basement membranes (GBM) and of antibodies to GBM in a patient with anti-GBM nephritis. (1989) (4)
Impact of training nephrologists from developing nations and strategies for sustaining a training program in its fourth decade. (2021) (4)
A study by immunofluorescence microscopy of the NC1 domain of collagen type IV in glomerular basement membranes of two patients with hereditary nephritis (2005) (3)
A morbid course in a girl with mixed connective tissue disease (1999) (3)
Interstitial Nephritis in Children (2016) (3)
Round 3 at JASN (2001 to 2007): Recollections of the Third Editorial Team (2010) (3)
An introduction to frontiers in nephrology. (2002) (3)
A NOVEL SIGNALING PATHWAY: FIBROBLAST NICOTINIC RECEPTOR (cid:2) 1 BINDS UROKINASE AND PROMOTES RENAL FIBROSIS (2009) (2)
JASN Moves On (2007) (2)
Patient and caregiver perspectives on blood pressure in children with chronic kidney disease. (2021) (2)
Subepithelial humps and microthrombi: looking for a mechanism. (2006) (1)
TINU: A Definitive Review. † 585 (1997) (1)
Perspectives of Clinicians on Shared Decision Making in Pediatric CKD: A Qualitative Study. (2022) (1)
Identifying important outcomes for young people with chronic kidney disease and their caregivers: a nominal group technique study (2019) (1)
And We're Off! (2002) (1)
Abstract 5461 In vivo Knockdown of Aortic Nicotinic Acetylcholine Receptor Alpha1 (nAChR{alpha}1) Diminishes Aortic Atherosclerosis and Valve Calcification (2009) (1)
Child and caregiver perspectives on access to psychosocial and educational support in pediatric chronic kidney disease: a focus group study (2022) (0)
Child and parental perspectives on communication and decision-making in pediatric chronic kidney disease: a focus group study (2018) (0)
Table of Contents (2020) (0)
CHAPTERR 4 Howw to deal with polarized Th 2 cells : exploringg the Achilles 1 heel . (2007) (0)
Contents Vol. 97, 2004 (2004) (0)
CHAPTER 34 – Interstitial Nephritis (2008) (0)
CLINICAL N EPHR O LOGY / ORIGIN A L AR T ICLE (1999) (0)
Kidneys of Normal Rats (1986) (0)
In Memoriam Norman J. Siegel, MD 1943–2006 (2006) (0)
Long-term outcome in pediatric systemic lupus erythematosus (1994) (0)
Cystinosis Research Foundation Final Progress Report Title : Cysteamine effects on extracellular matrix accumulation in chronic kidney disease (2009) (0)
translational physiology Plasminogen activator inhibitor-1 and the kidney (2002) (0)
Referees for 2001 (2002) (0)
Decreased Plasma Fibronectin Levels in Children With Hemolytic-Uremic Syndrome (1985) (0)
Acute Tubulointerstitial Disease in Rats with Experimental Neph rotic Syndrome (2007) (0)
Reviews submitted from August 1st, 2006 to August 31st, 2007 (2007) (0)

This paper list is powered by the following services:

Other Resources About Allison Eddy

en.wikipedia.org

What Schools Are Affiliated With Allison Eddy?

Allison Eddy is affiliated with the following schools: